AbbVie Acquires Celsius Therapeutics for $250M
AbbVie, a North Chicago, IL-based pharmaceutical company known for developing medicines and solutions addressing serious health issues, has announced the acquisition of Celsius Therapeutics, Inc., a privately held biotechnology company based in Cambridge, MA, focused on developing therapies for inflammatory diseases. Details of the Acquisition Under the terms of the agreement, AbbVie acquired all outstanding … Read more